Pancreatic Cancer Research

ResearcherNew York UniversityActive in the last 2 years

Marcovalerio Melis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7697-6796; OpenAlex author ID A5073180877, A5143166528. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
17
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 4 papers · 2025: 3 papers · 2026: 1 paper

Papers 10

  1. Survival Disparities in Early-Onset Pancreatic Cancer (EOPC): The Role of Socioeconomic Status and Healthcare Access. Co-author DOI 10.1002/jso.70148↗
  2. Evaluating the Association of Area Deprivation Index (ADI) on Postoperative Outcomes in Pancreatic Adenocarcinoma. Last author DOI 10.1002/jso.27996↗
  3. Impact of Environmental Quality on Pancreatic Cancer Outcomes Post Pancreatoduodenectomy: A Retrospective Cohort Study. Last author DOI 10.1007/s12029-025-01254-4↗
  4. Standard-Adherent Surgery and Guideline-Based Therapy in Pancreatic Cancer: A Multicenter Analysis. Last author DOI 10.1245/s10434-025-17467-7↗
  5. Machine learning to predict completion of treatment for pancreatic cancer. Last author DOI 10.1002/jso.27812↗
  6. Outcomes of minimally invasive vs. open pancreatoduodenectomies in pancreatic adenocarcinoma: analysis of ACS-NSQIP data. Last author DOI 10.1007/s00423-024-03454-1↗
  7. Modified 5-Item Frailty Index (mFI-5) may predict postoperative outcomes after pancreatoduodenectomy for pancreatic Cancer. Last author DOI 10.1007/s00423-024-03483-w↗
  8. Factors Influencing Immunotherapy Utilization in Stage IV Pancreatic Cancer: Impact of Race and Socioeconomics in the U.S. Last author DOI 10.1007/s12029-024-01119-2↗
  9. Can we downstage locally advanced pancreatic cancer to resectable? A phase I/II study of induction oxaliplatin and 5-FU chemoradiation. Co-author DOI 10.21037/jgo.2017.10.04↗
  10. Effect of intra-operative fluid volume on peri-operative outcomes after pancreaticoduodenectomy for pancreatic adenocarcinoma. Co-author DOI 10.1002/jso.22048↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Elliot Newman · 10 shared papers, 2012–2026 · strength 2.02
  2. Abdullah Khalid · 8 shared papers, 2024–2026 · strength 1.91
  3. Danielle K. DePeralta · 7 shared papers, 2024–2026 · strength 1.70
  4. Sepideh Gholami · 7 shared papers, 2024–2026 · strength 1.70
  5. Matthew John Weiss · 7 shared papers, 2024–2025 · strength 1.59
  6. Daniel A. King · 6 shared papers, 2024–2025 · strength 1.33
  7. Shamsher Ali Pasha · 5 shared papers, 2024–2025 · strength 1.11
  8. Lyudmyla Demyan · 4 shared papers, 2024–2025 · strength 0.90
  9. Oliver J. Standring · 3 shared papers, 2024–2025 · strength 0.69
  10. Matthew J. Weiss · 1 shared paper, 2026 · strength 0.32
  11. Deirdre Jill Cohen · 1 shared paper, 2018 · strength 0.08
  12. Salvatore Amodeo · 1 shared paper, 2018 · strength 0.08
  13. Theresa M. Ryan · 1 shared paper, 2018 · strength 0.08
  14. Howard S. Höchster · 1 shared paper, 2018 · strength 0.08
  15. Francesca Marcon · 1 shared paper, 2012 · strength 0.03
  16. Umut Sarpel · 1 shared paper, 2012 · strength 0.03
  17. George Miller · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.